GF Schwartz, HA Quigley - Survey of Ophthalmology, 2008 - Elsevier Adherence and persistence with chronic therapies is crucial to prevent disease
progression, such as in glaucoma. Patients report high rates of adherence, which
are not supported by pharmacy claims analysis. This article reviews the ... Cited by 7 - Related articles - All 20 versions
MY Kahook - Expert review of medical devices, 2007 - ingentaconnect.com Glaucoma is a leading cause of blindness worldwide. Currently, topical drops are
the mainstay of treatment for patients who suffer from this chronic disease.
Adherence to topical therapy is known to be affected by forgetfulness, ... Cited by 2 - Related articles - All 5 versions
F Djafari, MR Lesk, PJ Harasymowycz, D … - Journal of Glaucoma, 2009 - journals.lww.com Journal of Glaucoma. Wolters Kluwer Health Logo. All Issues. ... Related articles - All 2 versions
- ►duanesolution.com G Holló, P Kóthy, A Géczy, P Vargha - Journal of Glaucoma, 2009 - journals.lww.com Skip Navigation Links Home > April/May 2009 - Volume 18 - Issue 4 > Personality
Traits, Depression, and Objectively Measured Adh... ... Supported by Hungarian
National Health Grant (ETT) 001/2006 (GH). ... Reprints: Gábor Holló, ... Related articles - All 3 versions
LY Ho, L Camejo, MY Kahook, R Noecker, 2008 - pubmedcentral.nih.gov We studied the effects of audible and visual alarms on adherence with a
recommended dosing regimen in the management of glaucoma. Forty-two patients
were begun on therapy with the Travatan ® Dosing Aid (TDA) and randomly ... Related articles - All 6 versions